BRIEF-EMA Publishes Clinical Data Supporting Marketing Authorisation Of COVID Treatment Xevudy

European Medicines Agency:

* EMA: EMA PUBLISHED THE CLINICAL DATA SUPPORTING THE MARKETING AUTHORISATION OF COVID-19 TREATMENT XEVUDY (SOTROVIMAB): 12/05/2022

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)